AZACITIDINE
PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
MEITHEAL PHARMA
Indication
Chronic myelomonocytic leukemia
Chronic myelomonocytic leukemia is a rare clonal hematopoietic malignancy classified as an overlap myelodysplastic syndrome/myeloproliferative neoplasm. Read more about Chronic myelomonocytic leukemia
25 drugs 25 manufacturers
Drugs that treat it
Common Chronic myelomonocytic leukemia therapies.
AZACITIDINE
PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
PILNOVA PHARMA,
AZACITIDINE
PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
BLUEPOINT/ONCOP
AZACITIDINE
PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
MEITHEAL-NOVAPL
AZACITIDINE
PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
Hikma Pharmaceuticals USA
AZACITIDINE
PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
CIVICA, INC.
AZACITIDINE
PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
Pfizer Laboratories
Filter & compare in the drug finder →Opens the drug finder with Chronic myelomonocytic leukemia preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic myelomonocytic leukemia is a rare clonal hematopoietic malignancy classified as an overlap myelodysplastic syndrome/myeloproliferative neoplasm.
Primarily affecting the bone marrow and peripheral blood in older adults, it is characterized pathologically by sustained peripheral blood monocytosis alongside dysplastic myeloid precursors or excessive proliferation of mature myeloid lineages.
Clinical features typically include peripheral cytopenias, splenomegaly, constitutional symptoms, and an inherent risk of progression to acute myeloid leukemia.
- cancer.gov
Chronic myelomonocytic leukemia is a rare clonal hematopoietic malignancy classified as an overlap myelodysplastic syndrome/myeloproliferative neoplasm Primarily affecting the bone marrow and peripheral blood in older adults, it is characterized pathologically by sustained peripheral blood monocytosis alongside dysplastic myeloid precursors or excessive proliferation of mature myeloid lineages
- nih.gov
Chronic myelomonocytic leukemia is a rare clonal hematopoietic malignancy classified as an overlap myelodysplastic syndrome/myeloproliferative neoplasm Clinical features typically include peripheral cytopenias, splenomegaly, constitutional symptoms, and an inherent risk of progression to acute myeloid leukemia
- mdanderson.org
Primarily affecting the bone marrow and peripheral blood in older adults, it is characterized pathologically by sustained peripheral blood monocytosis alongside dysplastic myeloid precursors or excessive proliferation of mature myeloid lineages
- nih.gov
Primarily affecting the bone marrow and peripheral blood in older adults, it is characterized pathologically by sustained peripheral blood monocytosis alongside dysplastic myeloid precursors or excessive proliferation of mature myeloid lineages
- uvahealth.com
Clinical features typically include peripheral cytopenias, splenomegaly, constitutional symptoms, and an inherent risk of progression to acute myeloid leukemia
Personalize your experience
Follow Chronic myelomonocytic leukemia and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.